CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Repligen to Expand Cell Therapy Capabilities With BioLife Buyout

Positive
AI Analysis

Summary

Repligen announced the acquisition of BioLife to expand its cell therapy capabilities. The deal represents a strategic expansion of Repligen's portfolio in the cell therapy space.

Importance:7/10
Sentiment:
0.60
M&Acell therapyacquisition
Related Companies

Read the original article

Published by yahoo_finance on July 23, 2026 3:36 PM

Read Original